{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-410781","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2026-10-01T20:49:37+00:00","discovered_at":"2026-10-01T20:51:00.445767+00:00","generated_at":"2026-10-12T14:26:04.708675+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Achieve Life Sciences appoints Benjamin Halladay CFO effective Oct. 5, 2026; Mark Oki steps down","bullets":["Benjamin Halladay appointed CFO and principal financial officer effective Oct. 5, 2026; he was most recently CFO of Esperion Therapeutics from Nov. 2022 to Sept. 2026.","Halladay's compensation includes a $525,000 annual base salary, a discretionary bonus up to 40% of salary, 200,000 stock options and 200,000 RSUs.","Mark Oki stepped down as CFO effective Oct. 5, 2026; the company said his departure was not due to disagreement over financial statements or disclosures.","Halladay severance: nine months of base salary, or 12 months plus prorated bonus and accelerated option/RSU vesting if tied to a change in control.","Oki will receive severance under his Executive Employment Agreement dated Dec. 5, 2024, filed as Ex. 10.19 to the company's 2024 Form 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-410781","json":"https://secwatch.observer/filing/0001193125-26-410781.json","markdown":"https://secwatch.observer/filing/0001193125-26-410781.md","text":"https://secwatch.observer/filing/0001193125-26-410781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000119312526410781/0001193125-26-410781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000119312526410781/achv-20261001.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:26:04.708675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}